Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
Catheter Precision, Inc., a Delaware corporation, filed this Current Report on Form 8-K on August 14, 2024. The filing serves to announce the Company's financial results for the quarter ended June 30, 2024. The report was signed by Margrit Thomassen, Interim Chief Financial Officer, on August 15, 2024.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced in the body of this 8-K document.
Material Changes
No specific material changes versus the prior comparable period are detailed in the text of this filing. The document solely references the issuance of the press release containing the quarterly results.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information furnished in Item 2.02 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, this information is not subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement unless expressly stated otherwise by the registrant. No specific guidance, outlook, or risk factors are enumerated in the text of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release Issued on August 14, 2024) for actual revenue, net income, and cash flow figures for the quarter ended June 30, 2024.
- Verify the status of the Interim Chief Financial Officer and any potential leadership transitions.
- Confirm whether the press release contains updated forward-looking guidance or material risk disclosures not present in this summary.
- Check the NYSE American trading status for the common stock (VTAK) following the release of these results.